لابراتوار داروسازی دکتر عبیدی

دعبید | Stocks - Tehran Stock Exchange (TSE)

داروهای شیمیایی و گیاهی

Sector:

Market Type:

Status:

Last Price: - 0.00

Close Price: -

	2026/04/19 Fiscal Year 2025/12/2112 Month / Audited
Cash Generated from Operations	49.109 Trillion
Income Taxes Paid	-1.591 Trillion
Net Cash Flow from Operating Activities	47.518 Trillion
Proceeds from Sale of Property, Plant and Equipment	44.854 Billion
Purchases of Property, Plant and Equipment	-23.045 Trillion
Purchases of Intangible Assets	-585.059 Billion
Cash Paid to Acquire Long-Term Investments	-7.445 Trillion
Cash Paid to Acquire Short-Term Investments	-754.628 Billion
Cash Paid for Loans Granted to Others	-14.117 Trillion
Cash Received from Repayment of Loans Granted to Others	7.493 Trillion
Dividends Received	2.185 Trillion
Cash Received from Income on Other Investments	29.071 Billion
Net Cash Flow from Investing Activities	-31.756 Trillion
Net Cash Flow before Financing Activities	15.762 Trillion
Cash Received from Borrowings	136.624 Trillion
Repayments of Borrowings (Principal)	-127.087 Trillion
Interest Paid on Borrowings	-12.048 Trillion
Cash Received from Issuing Participation Bonds	2 Trillion
Interest Paid on Participation Bonds	-6.366 Trillion
Dividends Paid	-3.519 Trillion
Other Cash Flows from Financing Activities	2.646 Trillion
Net Cash Flow from Financing Activities	-7.748 Trillion
Net Increase (Decrease) in Cash	8.014 Trillion
Cash at Beginning of Period	6.023 Trillion
Effect of Exchange Rate Changes	231.079 Billion
Cash at End of Period	6.254 Trillion

At a Glance